Nuvectis Pharma (NVCT) Return on Assets [ROA] (2022 - 2026)
Nuvectis Pharma's Return on Assets [ROA] came in at -116.57% for Q2 2026, down 39.36 percentage points from -77.22% a year earlier and down 21.45 percentage points from the prior quarter.
Powered by 
Analysis
Nuvectis Pharma (NVCT) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For FY2025, Nuvectis Pharma's Return on Assets [ROA] was -105.10%, down 4.55 percentage points from FY2024.
- Return on Assets [ROA] carries a three-year change of +35.94 percentage points (FY2022 to FY2025).
- Going back by year, Return on Assets [ROA] was -100.55% in FY2024 (+11.90 pp), -112.45% in FY2023 (+28.59 pp) and -141.05% in FY2022.
- The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] since Q1 2022.
- Year-over-year, Return on Assets [ROA] increased in five of the last eight quarters, with an average year-over-year change of +7.10 percentage points.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q2 2025 (a gain of 33.81 percentage points), and the weakest in Q2 2026 (a drop of 39.36 percentage points).
- Business Quant data shows NVCT's Return on Assets [ROA] at -95.12% (Q1 2026), -78.58% (Q4 2025) and -81.08% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Nuvectis Pharma | 585.15 Mn | 585.15 Mn | - | -116.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -116.57% |
| Mar 31, 2026 | -95.12% |
| Dec 31, 2025 | -78.58% |
| Sep 30, 2025 | -81.08% |
| Jun 30, 2025 | -77.22% |
| Mar 31, 2025 | -82.70% |
| Dec 31, 2024 | -105.81% |
| Sep 30, 2024 | -108.83% |
| Jun 30, 2024 | -111.03% |
| Mar 31, 2024 | -115.08% |
| Dec 31, 2023 | -107.41% |
| Sep 30, 2023 | -94.63% |
| Jun 30, 2023 | -108.53% |
| Mar 31, 2023 | -110.29% |
| Dec 31, 2022 | -84.31% |
| Sep 30, 2022 | -74.95% |
| Jun 30, 2022 | -84.41% |
| Mar 31, 2022 | -130.29% |
API Access
Nuvectis Pharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();